A Passion for Science and a Commitment to Dermatology

Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. Dermavant leverages the Roivant platform to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development.

Dermavant Voices: Patient‑Focused Innovation

“THE ABILITY TO TRANSFORM LIVES”

Todd Zavodnick, Chief Executive Officer

“A PASSION FOR HELPING PEOPLE”

 Philip M Brown, MD, JD, Chief Medical Officer

“FUNDAMENTALLY CHANGING THE LIVES OF PATIENTS”

David Rubenstein, MD, PhD, Chief Scientific Officer

Latest News

June 5, 2019

Dermavant Sciences Announces First Patient Dosed i ...

Read More

May 15, 2019

Dermavant Sciences Appoints Timothy S. Nelson and ...

Read More

March 27, 2019

Dermavant Sciences Announces Appointment of Cyril ...

Read More